Data / Form D filings / OrthogenRx, Inc.
OrthogenRx, Inc.: Form D filings
OrthogenRx, Inc., a pharmaceuticals company in Doylestown, PA, filed 4 Form D notices with the SEC between 2013 and 2017. The latest, on March 30, 2017, reports $300,000 sold of a $3 million offering to 3 investors.
Find out what OrthogenRx, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3805 OLD EASTON ROAD, Doylestown, PA, 18902
- Phone
- (215) 693-1066
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Pennsylvania
- Year incorporated
- 2012
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1584198
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 30, 2017 | New notice | $3,000,000 | $300,000 | $2,700,000 | 3 | Mar 20, 2017 | sec.gov |
| Dec 8, 2015 | New notice | $7,500,000 | $135,313 | $7,364,687 | 11 | Oct 13, 2015 | sec.gov |
| Jul 28, 2014 | Amendment | $350,000 | $0 | $350,000 | 0 | Yet to occur | sec.gov |
| Sep 19, 2013 | New notice | $500,000 | $141,000 | $359,000 | 8 | Sep 12, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Daley | Executive Officer, Director, Promoter | |
| Tom Petro | Director | |
| Renee Selman | Director | |
| David Oster | Director | |
| David Owens | Director | |
| Berl Volker | Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
Every Form D from the week of Mar 27, 2017 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what OrthogenRx, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.